Widely available drug reduces head injury deaths

A low cost and widely available drug could reduce deaths in traumatic brain injury patients by as much as 20%, depending on the severity of injury, according to a major study. The researchers say that tranexamic acid (TXA), a drug that prevents bleeding into the brain by inhibiting blood clot breakdown, has the potential to save hundreds of thousands of lives.

Read more

New design strategy can help improve layered superconducting materials

Scientists have created a new layered superconducting material with a conducting layer made of bismuth, silver, tin, sulfur and selenium. The conducting layer features four distinct sublayers; by introducing more elements, they were able to achieve unparalleled customizability and a higher ''critical temperature'' below which superconductivity is observed, a key objective of superconductor research. Their design strategy may be applied to engineer new and improved superconducting materials.

Read more

Paclitaxel-coated devices are safe for unblocking arteries in lower limbs, study suggests

A study of nearly 65,000 people suggests that devices coated with a drug called paclitaxel that are used for widening blocked arteries in legs and feet are safe and not linked to an increase in deaths — a finding that contradicts smaller studies that led to the FDA issuing a safety alert about the use of paclitaxel-coated stents and balloons for arterial revascularization in the lower limbs in January 2019.

Read more

New capsule can orally deliver drugs that usually have to be injected

MIT engineers designed a drug capsule that can carry insulin or other protein drugs and protect them from the harsh environment of the gastrointestinal tract. When the capsule reaches the small intestine, it breaks down to reveal dissolvable microneedles that attach to the intestinal wall and release drug for uptake into the bloodstream.

Read more